Scientists are exploring the potential of tiny VNAR molecules derived from sharks for developing next-generation antibody therapies. These shark-derived molecules are noted for their exceptional stability and ability to access hard-to-reach molecular sites. Researchers are investigating their application in treating various conditions, including cancer, and for use in diagnostics and drug delivery, particularly across the blood-brain barrier. AI
RANK_REASON The item discusses scientific research into novel therapeutic molecules derived from a biological source. [lever_c_demoted from research: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →